Rafael Mayoral Monibas
Director, Translational Science, Metabolism Corcept Therapeutics Corcept Therapeutics
Seminars
Thursday 17th September 2026
Identifying High-Risk Patient Populations Through Clinical & Biomarker Insights to Enable Earlier Intervention & Improve Long-Term Outcomes in MASH
1:30 pm
- Integrating clinical, imaging, and multi-omics biomarkers to improve identification of high-risk MASH patients and enable earlier intervention
- Understanding disease progression trajectories across heterogeneous patient populations, including metabolic comorbidities and fibrosis risk
- Leveraging translational biomarkers to bridge preclinical findings with clinical outcomes and improve decision-making in drug development
- Applying risk stratification strategies to optimize patient selection, monitoring, and therapeutic timing in clinical trials and real-world settings
